Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol.
BMJ open(2023)
摘要
NCT05062837.
更多查看译文
关键词
health & safety, protocols & guidelines, hepatology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要